Quantum Technology

Baroness Jones of Whitchurch Excerpts

Tuesday 24th February 2026 Lords Chamber

[Lord Vallance of Balham (Lab)]

The noble Lord asks an important question. Quantum computers will be best for quantum problems. Drug discovery is a quantum problem, so it is exactly the sort of area for which this will be useful. We have five hubs specifically looking at both basic science and translation: a biomedical sensing hub dealing with imaging and other areas, including blood testing; a sensing, imaging and timing hub in Birmingham; an integrated network hub in Edinburgh; a quantum computing hub in Oxford; and a hub on position, navigation and timing. These are all about pulling the technology through in due course.

[Baroness Jones of Whitchurch (Lab)]

My Lords, given the worrying flow of some UK quantum companies taking money from or moving abroad, particularly to the US, in search of additional funding, is my noble friend the Minister confident that we are doing enough to map where in the UK the expertise is? It is important to us for national security, apart from anything else, that we have our own sovereign capability. Are we mapping it as well as we can and do we have an early warning system, such that we can intervene when some of these newly developing companies are thinking of going abroad, so that we can give them the support, funding or whatever else they need to stay in the UK, where we need them to grow?

[Lord Vallance of Balham (Lab)]

My noble friend asks an important question. There is no doubt that UK quantum companies look pretty attractive at the moment. We have a good idea of where those companies are, what their skills are and what is going on across the quantum space, but I believe there is a need to have all the levers in place to make sure that these companies stay in the UK. Yes, that is about funding, but also about regulation, procurement and giving the signals that can leverage the investment that these companies will need, as many of them are getting up to very significant valuations.

Merck Research Site

Baroness Jones of Whitchurch Excerpts

Thursday 11th September 2025 Lords Chamber

[Lord Vallance of Balham (Lab)]

I thank the noble Lord for raising the VPAG scheme. The VPAG scheme, which was negotiated under the previous Government, turned out with a figure of 23%, which was completely unexpected on both sides. The industry entered the scheme jointly with government, negotiated it and that is the number it came up with. We have been trying to negotiate a better position so that the industry gets more from that and is not hit with 23%. That is the deal going on at the moment. We are trying to make the environment better for companies and to rectify something that ended up in the wrong place.

[Baroness Jones of Whitchurch (Lab)]

My Lords, although this news is very disappointing, can my noble friend say something about the bigger picture? My understanding is that a number of other companies are continuing to invest here and that our dedicated life sciences action plan is being widely welcomed across the sector. Can he update the House on those issues?

[Lord Vallance of Balham (Lab)]

I thank my noble friend for her work over the past year as a Minister in two departments, which I think she did brilliantly. There are indeed other companies that are investing. In the same period, Moderna has invested £1 billion in the UK, and BioNTech has invested £2 billion in the UK. There is significant growth going on in Isomorphic Labs, one of the latest companies doing AI drug design. There are numerous examples of companies that are investing. We have a Life Sciences Sector Plan that has been welcomed by industry, and we know that as part of that the commercial environment for medicines in the UK needs to be improved.